{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:23:54Z","timestamp":1791289434861,"version":"4.3.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["CTN-0114"],"award-info":[{"award-number":["CTN-0114"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA049435"],"award-info":[{"award-number":["UG1DA049435"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA029831"],"award-info":[{"award-number":["AA029831"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-16-049-01-MPC"],"award-info":[{"award-number":["RSG-16-049-01-MPC"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG057557"],"award-info":[{"award-number":["AG057557"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG061388"],"award-info":[{"award-number":["AG061388"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG062272"],"award-info":[{"award-number":["AG062272"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG07664"],"award-info":[{"award-number":["AG07664"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY029297"],"award-info":[{"award-number":["EY029297"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2HD084068"],"award-info":[{"award-number":["DP2HD084068"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.phrs.2023.106960","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T19:03:10Z","timestamp":1697050990000},"page":"106960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["IUPHAR review \u2013 Data-driven computational drug repurposing approaches for opioid use disorder"],"prefix":"10.1016","volume":"199","author":[{"given":"Zhenxiang","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2613-2496","authenticated-orcid":false,"given":"Pingjian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2023.106960_bib1","unstructured":"The Centers for Disease Control and Prevention. (2023). Vital Statistics Rapid Release \u2013 Provisional Drug Overdose Data."},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/wps.20846","article-title":"The epidemic of fentanyl misuse and overdoses: challenges and strategies","volume":"20","author":"Volkow","year":"2021","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-019-4751-4","article-title":"Opioid use disorder and treatment: challenges and opportunities","volume":"19","author":"Hoffman","year":"2019","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.phrs.2023.106960_bib4","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). 2021 National Survey of Drug Use and Health (NSDUH) releases. Accessed March 31, 2023. \u3008https:\/\/www.samhsa.gov\/data\/release\/2021-national-survey-drug-use-and-health-nsduh-releases\u3009."},{"key":"10.1016\/j.phrs.2023.106960_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109551","article-title":"Prevalence of mental disorders among people with opioid use disorder: a systematic review and meta-analysis","volume":"238","author":"Santo","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.phrs.2023.106960_bib6","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster","year":"2017","journal-title":"Anesth. Analg."},{"issue":"4","key":"10.1016\/j.phrs.2023.106960_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000312","article-title":"High mortality among patients with opioid use disorder in a large healthcare system","volume":"11","author":"Hser","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.phrs.2023.106960_bib8","doi-asserted-by":"crossref","unstructured":"Oldfield, B.J., Munoz, N., McGovern, M.P., Funaro, M., Villanueva, M., Tetrault, J.M., & Edelman, E.J. (2018). Integration of care for HIV and opioid use disorder: a systematic review of interventions in clinical and community-based settings. AIDS (London, England).","DOI":"10.1097\/QAD.0000000000002125"},{"issue":"10","key":"10.1016\/j.phrs.2023.106960_bib9","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/cid\/ciac981","article-title":"Prevalence of testing for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among medicaid enrollees treated with medications for opioid use disorder in 11 states, 2016\u20132019","volume":"76","author":"Ahrens","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/add.15636","article-title":"Opioid use disorder and the brain: a clinical perspective","volume":"117","author":"Herlinger","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.phrs.2023.106960_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2008.03.017","article-title":"Executive functions and risky decision-making in patients with opiate dependence","volume":"97","author":"Brand","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.phrs.2023.106960_bib12","first-page":"189","article-title":"Neuropsychological consequences of chronic drug use: relevance to treatment approaches","volume":"6","author":"Cadet","year":"2015","journal-title":"Front Psychol."},{"key":"10.1016\/j.phrs.2023.106960_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11065-007-9041-y","article-title":"Neuropsychological con-sequences of opiate use","volume":"17","author":"Gruber","year":"2007","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.phrs.2023.106960_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-021-00275-1","article-title":"Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review","volume":"16","author":"Krawczyk","year":"2021","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.phrs.2023.106960_bib16","doi-asserted-by":"crossref","unstructured":"Wen, H., Xiang, X., Jiang, Y., Zhang, H., Zhang, P., Chen, R.,. & Lu, L. (2023). Comparative efficacy of psychosocial interventions for opioid\u2010dependent people receiving methadone maintenance treatment: A network meta\u2010analysis. Addiction.","DOI":"10.1111\/add.16167"},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jama.2018.8826","article-title":"Helping to end addiction over the long-term: the research plan for the NIH HEAL initiative","volume":"320","author":"Collins","year":"2018","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: new estimates of drug development costs","volume":"22","author":"DiMasi","year":"2003","journal-title":"J. Health Econ."},{"key":"10.1016\/j.phrs.2023.106960_bib19","unstructured":"National Academies of Sciences, Engineering, and Medicine. (2018). Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop."},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/npp.2011.84","article-title":"New medications for substance use disorders: challenges and opportunities","volume":"37","author":"Volkow","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2023.106960_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-022-08272-z","article-title":"Drug repurposing: a systematic review on root causes, barriers and facilitators","volume":"22","author":"Krishnamurthy","year":"2022","journal-title":"BMC Health Serv. Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","article-title":"A review of computational drug repurposing","volume":"27","author":"Park","year":"2019","journal-title":"Transl. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106960_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2022.104133","article-title":"KG-Predict: A knowledge graph computational framework for drug repurposing","volume":"132","author":"Gao","year":"2022","journal-title":"J. Biomed. Inform."},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-020-00450-7","article-title":"A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions","volume":"12","author":"Jarada","year":"2020","journal-title":"J. Chemin.-."},{"key":"10.1016\/j.phrs.2023.106960_bib27","first-page":"59","article-title":"Computer-aided drug repurposing for cancer therapy: approaches and opportunities to challenge anticancer targets","volume":"Vol. 68","author":"Mottini","year":"2021"},{"key":"10.1016\/j.phrs.2023.106960_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107930","article-title":"Drug repurposing for COVID-19: approaches, challenges and promising candidates","volume":"228","author":"Ng","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2023.106960_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.tips.2019.06.003","article-title":"Insights into computational drug repurposing for neurodegenerative disease","volume":"40","author":"Paranjpe","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.phrs.2023.106960_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13313","article-title":"Exploring opportunities for drug repurposing and precision medicine in cannabis use disorder using genetics","volume":"28","author":"Greco","year":"2023","journal-title":"Addict. Biol."},{"key":"10.1016\/j.phrs.2023.106960_bib31","doi-asserted-by":"crossref","unstructured":"Gao, Z., Winhusen, T.J., Gorenflo, M., Ghitza, U.E., Davis, P.B., Kaelber, D.C., & Xu, R. (2023). Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence\u2010based prediction, expert evaluation, clinical corroboration and mechanism of action analyses. Addiction.","DOI":"10.1111\/add.16168"},{"key":"10.1016\/j.phrs.2023.106960_bib32","article-title":"Past and current drug repurposing clinical trials to treat cognition in methamphetamine use: a scoping review of pharmacotherapy candidates","author":"Peters","year":"2023","journal-title":"Addict. Neurosci."},{"key":"10.1016\/j.phrs.2023.106960_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106921","article-title":"Machine-learning repurposing of DrugBank compounds for opioid use disorder","volume":"160","author":"Feng","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"9","key":"10.1016\/j.phrs.2023.106960_bib34","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1038\/s41380-020-01011-y","article-title":"Drug repurposing for opioid use disorders: integration of computational prediction, clinical corroboration, and mechanism of action analyses","volume":"26","author":"Zhou","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"96","key":"10.1016\/j.phrs.2023.106960_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001318","article-title":"Discovery and preclinical validation of drug indications using compendia of public gene expression data","volume":"3","author":"Sirota","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"7\u20138","key":"10.1016\/j.phrs.2023.106960_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.drudis.2012.07.014","article-title":"Transcriptional data: a new gateway to drug repositioning?","volume":"18","author":"Iorio","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.phrs.2023.106960_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/bib\/bbr013","article-title":"Exploiting drug\u2013disease relationships for computational drug repositioning","volume":"12","author":"Dudley","year":"2011","journal-title":"Brief. Bioinforma."},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41398-021-01737-5","article-title":"Ibrutinib as a potential therapeutic for cocaine use disorder","volume":"11","author":"Huggett","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"D1","key":"10.1016\/j.phrs.2023.106960_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx1063","article-title":"Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data","volume":"46","author":"Koleti","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.phrs.2023.106960_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/clpt.2009.103","article-title":"Systematic evaluation of drug\u2013disease relationships to identify leads for novel drug uses","volume":"86","author":"Chiang","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2023.106960_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71880","article-title":"A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer","volume":"11","author":"Yang","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.phrs.2023.106960_bib42","first-page":"2019","article-title":"Drug repurposing for Alzheimer\u2019s disease based on transcriptional profiling of human iPSC-derived cortical neurons","author":"Williams","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.phrs.2023.106960_bib43","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41386-021-01059-6","article-title":"Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing","volume":"46","author":"Fabbri","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2023.106960_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.893303","article-title":"Whole transcriptome sequencing of peripheral blood shows that immunity\/GnRH\/PI3K-Akt pathways are associated with opioid use disorder","volume":"13","author":"Dai","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"12","key":"10.1016\/j.phrs.2023.106960_bib45","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.1038\/s41380-021-01259-y","article-title":"Angiogenic gene networks are dysregulated in opioid use disorder: evidence from multi-omics and imaging of postmortem human brain","volume":"26","author":"Mendez","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.phrs.2023.106960_bib46","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phrs.2023.106960_bib48","first-page":"20503","article-title":"Equibind: Geometric deep learning for drug binding structure prediction","author":"St\u00e4rk","year":"2022","journal-title":"Int. Conf. Mach. Learn."},{"key":"10.1016\/j.phrs.2023.106960_bib49","first-page":"7236","article-title":"Tankbind: trigonometry-aware neural networks for drug-protein binding structure prediction","volume":"35","author":"Lu","year":"2022","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.phrs.2023.106960_bib50","article-title":"Diffdock: diffusion steps, twists, and turns for molecular docking","author":"Corso","year":"2022","journal-title":"arXiv Prepr. arXiv"},{"key":"10.1016\/j.phrs.2023.106960_bib51","article-title":"Do deep learning models really outperform traditional approaches in molecular docking?","author":"Yu","year":"2023","journal-title":"arXiv Prepr. arXiv"},{"issue":"5","key":"10.1016\/j.phrs.2023.106960_bib52","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/bib\/bbz103","article-title":"Computational\/in silico methods in drug target and lead prediction","volume":"21","author":"Agamah","year":"2020","journal-title":"Brief. Bioinforma."},{"issue":"22\u201323","key":"10.1016\/j.phrs.2023.106960_bib53","first-page":"5545","article-title":"DeepPurpose: a deep learning library for drug\u2013target interaction prediction","volume":"36","author":"Huang","year":"2020","journal-title":"Bioinformatics"},{"issue":"24","key":"10.1016\/j.phrs.2023.106960_bib54","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220778120","article-title":"Contrastive learning in protein language space predicts interactions between drugs and protein targets","volume":"120","author":"Singh","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2023.106960_bib55","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/bioinformatics\/btaa010","article-title":"Network-based prediction of drug\u2013target interactions using an arbitrary-order proximity embedded deep forest","volume":"36","author":"Zeng","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.phrs.2023.106960_bib56","doi-asserted-by":"crossref","unstructured":"Dalk\u0131ran, A., Atakan, A., Rifaio\u011flu, A.S., Martin, M.J., Atalay, R.\u00c7., Acar, A.C.,. & Atalay, V. (2023). Transfer learning for drug\u2013target interaction prediction. Bioinformatics, 39(Supplement_1), i103-i110.","DOI":"10.1093\/bioinformatics\/btad234"},{"issue":"25","key":"10.1016\/j.phrs.2023.106960_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg7865","article-title":"Accelerating drug target inhibitor discovery with a deep generative foundation model","volume":"9","author":"Chenthamarakshan","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2023.106960_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.202201683R","article-title":"Molecular interaction networks and drug development: novel approach to drug target identification and drug repositioning","volume":"37","author":"Loscalzo","year":"2023","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.phrs.2023.106960_bib59","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/bib\/bbz091","article-title":"Heterogeneous information network and its application to human health and disease","volume":"21","author":"Ding","year":"2020","journal-title":"Brief. Bioinforma."},{"key":"10.1016\/j.phrs.2023.106960_bib60","series-title":"2012 IEEE international conference on bioinformatics and biomedicine","first-page":"1","article-title":"A new method for computational drug repositioning using drug pairwise similarity","author":"Li","year":"2012"},{"key":"10.1016\/j.phrs.2023.106960_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-018-2220-4","article-title":"Predicting drug-disease associations by using similarity constrained matrix factorization","volume":"19","author":"Zhang","year":"2018","journal-title":"BMC Bioinforma."},{"issue":"7","key":"10.1016\/j.phrs.2023.106960_bib62","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/bioinformatics\/btw737","article-title":"Context-sensitive network-based disease genetics prediction and its implications in drug discovery","volume":"33","author":"Chen","year":"2017","journal-title":"Bioinformatics"},{"issue":"D1","key":"10.1016\/j.phrs.2023.106960_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9. 1: protein-protein interaction networks, with increased coverage and integration","volume":"41","author":"Franceschini","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.phrs.2023.106960_bib64","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/bioinformatics\/btab767","article-title":"DeepKG: an end-to-end deep learning-based workflow for biomedical knowledge graph extraction, optimization and applications","volume":"38","author":"Li","year":"2022","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.phrs.2023.106960_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac404","article-title":"A review of biomedical datasets relating to drug discovery: a knowledge graph perspective","volume":"23","author":"Bonner","year":"2022","journal-title":"Brief. Bioinforma."},{"issue":"4","key":"10.1016\/j.phrs.2023.106960_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa344","article-title":"PharmKG: a dedicated knowledge graph benchmark for bomedical data mining","volume":"22","author":"Zheng","year":"2021","journal-title":"Brief. Bioinforma."},{"key":"10.1016\/j.phrs.2023.106960_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2021.103838","article-title":"Learning Drug-Disease-Target Embedding (DDTE) from knowledge graphs to inform drug repurposing hypotheses","volume":"119","author":"Moon","year":"2021","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.phrs.2023.106960_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1181711","article-title":"Drug repurposing for reducing the risk of cataract extraction in patients with diabetes mellitus: integration of artificial intelligence-based drug prediction and clinical corroboration","volume":"14","author":"Gao","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2023.106960_bib69","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/bioinformatics\/btv055","article-title":"Similarity-based prediction for anatomical therapeutic chemical classification of drugs by integrating multiple data sources","volume":"31","author":"Liu","year":"2015","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.phrs.2023.106960_bib70","article-title":"Drug repositioning by kernel-based integration of molecular structure, molecular activity, and phenotype data","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.phrs.2023.106960_bib71","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/acs.molpharmaceut.6b00248","article-title":"Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data","volume":"13","author":"Aliper","year":"2016","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2023.106960_bib72","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/cells8070705","article-title":"Convolutional neural network and bidirectional long short-term memory-based method for predicting drug\u2013disease associations","volume":"8","author":"Xuan","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2023.106960_bib73","first-page":"3371","article-title":"Interpretable drug target prediction using deep neural representation","volume":"Vol. 2018","author":"Gao","year":"2018","journal-title":"IJCAI"},{"key":"10.1016\/j.phrs.2023.106960_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.knosys.2020.106585","article-title":"SNF\u2013CVAE: computational method to predict drug\u2013disease interactions using similarity network fusion and collective variational autoencoder","volume":"212","author":"Jarada","year":"2021","journal-title":"Knowl. -Based Syst."},{"issue":"Supplement_1","key":"10.1016\/j.phrs.2023.106960_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btaa437","article-title":"Toward heterogeneous information fusion: bipartite graph convolutional networks for in silico drug repurposing","volume":"36","author":"Wang","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.phrs.2023.106960_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105992","article-title":"A computational approach to drug repurposing using graph neural networks","volume":"150","author":"Doshi","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib77","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat. Rev. Methods Prim."},{"key":"10.1016\/j.phrs.2023.106960_bib78","article-title":"Mendelian randomization as a tool to inform drug development using human genetics","volume":"1","author":"Daghlas","year":"2023","journal-title":"Camb. Prism.: Precis. Med."},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib79","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","article-title":"Genetics meets proteomics: perspectives for large population-based studies","volume":"22","author":"Suhre","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.phrs.2023.106960_bib80","doi-asserted-by":"crossref","unstructured":"Schmidt, A.F., Finan, C., Gordillo-Mara\u00f1\u00f3n, M., Asselbergs, F.W., Freitag, D.F., Patel, R.S.,. & Hingorani, A.D. (2020). Genetic drug target validation using Mendelian randomisation. Nature communications, 11(1), 3255.","DOI":"10.1038\/s41467-020-16969-0"},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib81","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41386-022-01456-5","article-title":"Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders","volume":"48","author":"Liu","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2023.106960_bib82","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41591-021-01310-z","article-title":"Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19","volume":"27","author":"Gaziano","year":"2021","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.phrs.2023.106960_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001866","article-title":"Vitamin D and risk of multiple sclerosis: a Mendelian randomization study","volume":"12","author":"Mokry","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.phrs.2023.106960_bib84","first-page":"1","article-title":"Aspirin use and risk of Alzheimer\u2019s disease: a 2-sample mendelian randomization study","author":"Ding","year":"2023","journal-title":"J. Alzhei\u2019er'S. Dis., (Prepr. )"},{"issue":"8","key":"10.1016\/j.phrs.2023.106960_bib85","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/gerona\/glac255","article-title":"Linear and nonlinear associations between vitamin D and grip strength: a mendelian randomization study in UK biobank","volume":"78","author":"Pinto Pereira","year":"2023","journal-title":"J. Gerontol.: Ser. A"},{"key":"10.1016\/j.phrs.2023.106960_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108276","article-title":"Genome-wide association analysis of opioid use disorder: A novel approach using clinical data","volume":"217","author":"Song","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.phrs.2023.106960_bib87","unstructured":"TriNetX, 2022. [Internet]. Available from: https:\/\/live.trinetx.com\/tnx\/studies."},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103422","article-title":"Drug repurposing using real-world data","volume":"28","author":"Tan","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2023.106960_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110958","article-title":"Potential effect of antidepressants on remission from cocaine use disorder-a nationwide matched retrospective cohort study","author":"Gao","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.phrs.2023.106960_bib90","first-page":"1","article-title":"Association of aspirin use with reduced risk of developing Alzheimer\u2019s disease in elderly ischemic stroke patients: a retrospective cohort study","author":"Gorenflo","year":"2022","journal-title":"J. Alzheimer'S. Dis., (Prepr. )"},{"issue":"4","key":"10.1016\/j.phrs.2023.106960_bib91","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/nedt.2006.2.4.455","article-title":"Atomoxetine: a novel treatment for child and adult ADHD","volume":"2","author":"Ledbetter","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib92","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.apmr.2005.08.131","article-title":"Atomoxetine enhances a short-term model of plasticity in humans","volume":"87","author":"Foster","year":"2006","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib93","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1369-1600.2008.00138.x","article-title":"Norepinephrine and stimulant addiction","volume":"14","author":"Sofuoglu","year":"2009","journal-title":"Addict. Biol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106960_bib94","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2008.01.008","article-title":"Abuse liability assessment of atomoxetine in a drug-abusing population","volume":"95","author":"Jasinski","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.phrs.2023.106960_bib95","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","article-title":"There and back again: a tale of norepinephrine and drug addiction","volume":"32","author":"Weinshenker","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2023.106960_bib96","doi-asserted-by":"crossref","unstructured":"Sacco, K.A., Creeden, C., Reutenauer, E.L., Vessicchio, J.C., Weinberge, A.H., & George, T.P. (2009). Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia.","DOI":"10.1016\/j.schres.2008.09.026"},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-859X-11-6","article-title":"Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers","volume":"11","author":"Silverstone","year":"2012","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.phrs.2023.106960_bib98","unstructured":"Huecker, M.R., Smiley, A., & Saadabadi, A. (2017). Bupropion."},{"issue":"4","key":"10.1016\/j.phrs.2023.106960_bib99","first-page":"159","article-title":"A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor","volume":"6","author":"Stahl","year":"2004","journal-title":"Prim. care Companion J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2023.106960_bib100","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.pharep.2018.04.003","article-title":"Bupropion attenuates morphine tolerance and dependence: Possible role of glutamate, norepinephrine, inflammation, and oxidative stress","volume":"70","author":"Hamdy","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib101","first-page":"231","article-title":"The effects of bupropion and varenicline on morphine withdrawal syndrome in rats","volume":"11","author":"Yunuso\u011flu","year":"2022","journal-title":"Abant T\u0131p Derg."},{"key":"10.1016\/j.phrs.2023.106960_bib102","unstructured":"Jilani, T.N., Gibbons, J.R., Faizy, R.M., & Saadabadi, A. (2018). Mirtazapine."},{"key":"10.1016\/j.phrs.2023.106960_bib103","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00023210-200923050-00006","article-title":"Mirtazapine: a review of its use in major depression and other psychiatric disorders","volume":"23","author":"Croom","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2023.106960_bib104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2012.07.007","article-title":"The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization","volume":"1472","author":"Graves","year":"2012","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.phrs.2023.106960_bib105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pharmthera.2012.08.013","article-title":"Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside","volume":"136","author":"Graves","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2023.106960_bib106","first-page":"337","article-title":"Mirtazapine in the treatment of cocaine-dependence in patients with methadone","volume":"30","author":"PL","year":"2002","journal-title":"Actas Esp. De. Psiquiatr."},{"issue":"5","key":"10.1016\/j.phrs.2023.106960_bib107","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1007\/s11469-021-00547-6","article-title":"Effect of mirtazapine on craving in cocaine-dependent patients","volume":"20","author":"Nanni-Alvarado","year":"2022","journal-title":"Int. J. Ment. Health Addict."},{"issue":"11","key":"10.1016\/j.phrs.2023.106960_bib108","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archgenpsychiatry.2011.124","article-title":"Mirtazapine to reduce methamphetamine use: a randomized controlled trial","volume":"68","author":"Colfax","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.phrs.2023.106960_bib109","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ajhp\/54.6.643","article-title":"Tramadol: a new centrally acting analgesic","volume":"54","author":"Lewis","year":"1997","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.phrs.2023.106960_bib110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5812\/aapm.119156","article-title":"Full opioid agonists and tramadol: pharmacological and clinical considerations","volume":"11","author":"Edinoff","year":"2021","journal-title":"Anesthesiol. Pain. Med."},{"issue":"5","key":"10.1016\/j.phrs.2023.106960_bib111","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/19336950.2015.1069450","article-title":"The mechanism of \u03bc-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence","volume":"9","author":"Bao","year":"2015","journal-title":"Channels"},{"key":"10.1016\/j.phrs.2023.106960_bib112","first-page":"7","article-title":"Tramadol for the management of opioid withdrawal: a systematic review of randomized clinical trials","volume":"12","author":"Shah","year":"2020","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.phrs.2023.106960_bib113","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jamapsychiatry.2017.1838","article-title":"Efficacy of tramadol extended-release for opioid withdrawal: a randomized clinical trial","volume":"74","author":"Dunn","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2023.106960_bib114","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5055\/jom.2017.0408","article-title":"Tramadol for maintenance in opioid dependence: a retrospective chart revie","volume":"13","author":"Sarkar","year":"2017","journal-title":"J. Opioid Manag."},{"issue":"4","key":"10.1016\/j.phrs.2023.106960_bib115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J069v22n04_03","article-title":"The use of tramadol for acute heroin withdrawal: a comparison to clonidine","volume":"22","author":"Sobey","year":"2004","journal-title":"J. Addict. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2023.106960_bib116","first-page":"579","article-title":"Review of olanzapine in the management of bipolar disorders","volume":"3","author":"Narasimhan","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"10","key":"10.1016\/j.phrs.2023.106960_bib117","first-page":"28","article-title":"In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug","volume":"58","author":"Bymaster","year":"1997","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2023.106960_bib118","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/wnf.0b013e31803354f6","article-title":"Combination of olanzapine with opioid-agonists in the treatment of heroin-addicted patients affected by comorbid schizophrenia spectrum disorders","volume":"30","author":"Gerra","year":"2007","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib119","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17512433.2019.1570845","article-title":"A meta-analysis of naldemedine for the treatment of opioid-induced constipation","volume":"12","author":"Song","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2023.106960_bib120","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s40265-019-01160-7","article-title":"Naldemedine: a review in opioid-induced constipation","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2023.106960_bib121","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221078638","article-title":"Update on the role of naldemedine in opioid-induced constipation in patients with chronic noncancer pain","volume":"15","author":"BouSaba","year":"2022","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"10","key":"10.1016\/j.phrs.2023.106960_bib122","first-page":"601","article-title":"Naldemedine (Symproic) for the treatment of opioid-induced constipation","volume":"43","author":"Hu","year":"2018","journal-title":"Pharm. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2023.106960_bib123","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1177\/10600280211070330","article-title":"Olanzapine\/samidorphan: new drug approved for treating bipolar I disorder and schizophrenia","volume":"56","author":"Monahan","year":"2022","journal-title":"Ann. Pharmacother."},{"issue":"6","key":"10.1016\/j.phrs.2023.106960_bib124","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"J. Am. Soc. Anesthesiol."},{"issue":"10","key":"10.1016\/j.phrs.2023.106960_bib125","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/acer.13849","article-title":"Effects of the opioid system modulator, samidorphan, on measures of alcohol consumption and patient\u2010reported outcomes in adults with alcohol dependence","volume":"42","author":"O'Malley","year":"2018","journal-title":"Alcohol.: Clin. Exp. Res."},{"key":"10.1016\/j.phrs.2023.106960_bib126","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/B978-0-12-420118-7.00010-X","article-title":"Mixed kappa\/mu partial opioid agonists as potential treatments for cocaine dependence","volume":"69","author":"Bidlack","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106960_bib127","doi-asserted-by":"crossref","first-page":"4","DOI":"10.51847\/ZqD8WfwA6Y","article-title":"Estimation of olanzapine and samidorphan in bulk and pharmaceutical dosage form using RP-HPL","volume":"11","author":"Syed","year":"2022","journal-title":"Int. J. Pharm. Res. Allied Sci."},{"key":"10.1016\/j.phrs.2023.106960_bib128","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.2147\/JPR.S271456","article-title":"Levorphanol in the perioperative setting: decreasing opioid requirements while improving pain management","author":"Page","year":"2020","journal-title":"J. Pain. Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106960_bib129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(25)39140-8","article-title":"Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons","volume":"242","author":"Choi","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2023.106960_bib130","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/pme.12795","article-title":"Is levorphanol a better option than methadone?","volume":"16","author":"Pham","year":"2015","journal-title":"Pain. Med."},{"issue":"3","key":"10.1016\/j.phrs.2023.106960_bib131","first-page":"202","article-title":"Levorphanol for the treatment of severe chronic pain","volume":"11","author":"McNulty","year":"2007","journal-title":"Int. J. Pharm. Compd."},{"issue":"21","key":"10.1016\/j.phrs.2023.106960_bib132","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.3390\/cancers13215492","article-title":"Drug repositioning based on the reversal of gene expression signatures identifies TOP2A as a therapeutic target for rectal cancer","volume":"13","author":"Carvalho","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.phrs.2023.106960_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150460","article-title":"Drug repositioning for cancer therapy based on large-scale drug-induced transcriptional signatures","volume":"11","author":"Lee","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2023.106960_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.989174","article-title":"Drug repurposing using meta-analysis of gene expression in Alzheimer\u2019s disease","volume":"16","author":"Jang","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2023.106960_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2022.102283","article-title":"Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach","volume":"96","author":"Advani","year":"2022","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib136","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5114\/wo.2014.47136","article-title":"Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"2015","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol. \/Wsp\u00f3\u0142czesna Onkol."},{"issue":"7757","key":"10.1016\/j.phrs.2023.106960_bib137","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib138","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cels.2017.11.001","article-title":"The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations","volume":"6","author":"Keenan","year":"2018","journal-title":"Cell Syst."},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib139","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41597-022-01687-7","article-title":"NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotency","volume":"10","author":"Matlock","year":"2023","journal-title":"Sci. Data"},{"issue":"1","key":"10.1016\/j.phrs.2023.106960_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npjsba.2016.15","article-title":"L1000CDS2: LINCS L1000 characteristic direction signatures search engine","volume":"2","author":"Duan","year":"2016","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.phrs.2023.106960_bib142","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12031-013-0019-3","article-title":"Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells","volume":"51","author":"Caputi","year":"2013","journal-title":"J. Mol. Neurosci."},{"issue":"43","key":"10.1016\/j.phrs.2023.106960_bib143","doi-asserted-by":"crossref","first-page":"967","DOI":"10.15585\/mmwr.mm6843a3","article-title":"Racial\/ethnic and age group differences in opioid and synthetic opioid\u2013involved overdose deaths among adults aged\u2265 18 years in metropolitan areas\u2014United States, 2015\u20132017","volume":"68","author":"Lippold","year":"2019","journal-title":"Morb. Mortal. Wkly. Rep."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182300316X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182300316X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:50:35Z","timestamp":1760914235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182300316X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":142,"alternative-id":["S104366182300316X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106960","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IUPHAR review \u2013 Data-driven computational drug repurposing approaches for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106960"}}